Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Giredestrant

Catalog No. T11399Cas No. 1953133-47-5
Alias GDC-9545

Giredestrant (GDC-9545) potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain. Giredestrant has anti-tumor activity. Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen receptor (ER) antagonist.

Giredestrant

Giredestrant

Purity: 98.96%
Catalog No. T11399Alias GDC-9545Cas No. 1953133-47-5
Giredestrant (GDC-9545) potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain. Giredestrant has anti-tumor activity. Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen receptor (ER) antagonist.
Pack SizePriceAvailabilityQuantity
1 mg$139In Stock
5 mg$289In Stock
10 mg$463In Stock
25 mg$868In Stock
50 mg$1,390In Stock
100 mg$2,180In Stock
200 mg$2,960In Stock
1 mL x 10 mM (in DMSO)$332In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Giredestrant"

Select Batch
Purity:98.96%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Giredestrant (GDC-9545) potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain. Giredestrant has anti-tumor activity. Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen receptor (ER) antagonist.
In vitro
The highly potent in vivo efficacy of Giredestrant likely arises due to the particular combination of high binding potency, full suppression of ER signaling, and an improved DMPK profile.Giredestrant (GDC-9545) is a novel ER antagonist and clinical candidate that combines desirable mechanistic and pre-clinical DMPK attributes.
AliasGDC-9545
Chemical Properties
Molecular Weight522.55
FormulaC27H31F5N4O
Cas No.1953133-47-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (191.37 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9137 mL9.5685 mL19.1369 mL95.6846 mL
5 mM0.3827 mL1.9137 mL3.8274 mL19.1369 mL
10 mM0.1914 mL0.9568 mL1.9137 mL9.5685 mL
20 mM0.0957 mL0.4784 mL0.9568 mL4.7842 mL
50 mM0.0383 mL0.1914 mL0.3827 mL1.9137 mL
100 mM0.0191 mL0.0957 mL0.1914 mL0.9568 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Giredestrant | purchase Giredestrant | Giredestrant cost | order Giredestrant | Giredestrant chemical structure | Giredestrant in vitro | Giredestrant formula | Giredestrant molecular weight